-
1
-
-
0013844612
-
A soluble protein characteristic of the nervous system
-
Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-44.
-
(1965)
Biochem Biophys Res Commun
, vol.19
, pp. 739-744
-
-
Moore, B.W.1
-
2
-
-
0034995073
-
S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
-
Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-68.
-
(2001)
Int J Biochem Cell Biol
, vol.33
, pp. 637-668
-
-
Donato, R.1
-
3
-
-
0033663782
-
Elimination of S100B and renal function after cardiac surgery
-
Jonsson H, Johnsson P, Hoglund P, Alling C, Blomquist S. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000;14:698-701.
-
(2000)
J Cardiothorac Vasc Anesth
, vol.14
, pp. 698-701
-
-
Jonsson, H.1
Johnsson, P.2
Hoglund, P.3
Alling, C.4
Blomquist, S.5
-
4
-
-
0031949683
-
Plasma S100B protein concentration in healthy adults is ageand sex-independent
-
Wiesmann M, Missler U, Gottmann D, Gehring S. Plasma S100B protein concentration in healthy adults is ageand sex-independent. Clin Chem 1998;44:1056-8.
-
(1998)
Clin Chem
, vol.44
, pp. 1056-1058
-
-
Wiesmann, M.1
Missler, U.2
Gottmann, D.3
Gehring, S.4
-
5
-
-
0035810979
-
Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans
-
Bottiger BW, Mobes S, Glatzer R, Bauer H, Gries A, Bartsch P, et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001;103:2694-8.
-
(2001)
Circulation
, vol.103
, pp. 2694-2698
-
-
Bottiger, B.W.1
Mobes, S.2
Glatzer, R.3
Bauer, H.4
Gries, A.5
Bartsch, P.6
-
6
-
-
0033766279
-
Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein
-
Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000;31:2670-7.
-
(2000)
Stroke
, vol.31
, pp. 2670-2677
-
-
Herrmann, M.1
Vos, P.2
Wunderlich, M.T.3
de Bruijn, C.H.4
Lamers, K.J.5
-
7
-
-
0033852159
-
Traumatic brain damage: Serum S-100 protein measurements related to neuroradiological findings
-
Rommer B, Ingebrigtsen T, Kongstad P, Borgesen SE. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 2000;17:641-7.
-
(2000)
J Neurotrauma
, vol.17
, pp. 641-647
-
-
Rommer, B.1
Ingebrigtsen, T.2
Kongstad, P.3
Borgesen, S.E.4
-
8
-
-
0036830112
-
Head injury outcome prediction in the emergency department: A role for protein S-100B?
-
Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: a role for protein S-100B? J Neurol Neurosurg Psychiatry 2002;73:97-100.
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.73
, pp. 97-100
-
-
Townend, W.J.1
Guy, M.J.2
Pani, M.A.3
Martin, B.4
Yates, D.W.5
-
10
-
-
0032881853
-
Elevated plasma level of S-100B protein in schizophrenic patients
-
Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, et al. Elevated plasma level of S-100B protein in schizophrenic patients. Biol Psychiatry 1999;45:1508-11.
-
(1999)
Biol Psychiatry
, vol.45
, pp. 1508-1511
-
-
Wiesmann, M.1
Wandinger, K.P.2
Missler, U.3
Eckhoff, D.4
Rothermundt, M.5
Arolt, V.6
-
11
-
-
0034674725
-
Decreased S100-b protein in schizophrenia: Preliminary evidence
-
Gattaz WF, Lara DR, Elkis H, Portela LV, Goncalves CA, Tort AB, et al. Decreased S100-b protein in schizophrenia: preliminary evidence. Schizophr Res 2000;43:91-5.
-
(2000)
Schizophr Res
, vol.43
, pp. 91-95
-
-
Gattaz, W.F.1
Lara, D.R.2
Elkis, H.3
Portela, L.V.4
Goncalves, C.A.5
Tort, A.B.6
-
12
-
-
0035085349
-
Increased serum S100B protein in schizophrenia: A study in medication-free patients
-
Lara DR, Gama CS, Belmonte-de-Abreu P, Portela LV, Goncalves CA, Fonseca M, et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 2001;35:11-4.
-
(2001)
J Psychiatr Res
, vol.35
, pp. 11-14
-
-
Lara, D.R.1
Gama, C.S.2
Belmonte-de-Abreu, P.3
Portela, L.V.4
Goncalves, C.A.5
Fonseca, M.6
-
13
-
-
0034979240
-
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology
-
Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, et al. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 2001;6:445-9.
-
(2001)
Mol Psychiatry
, vol.6
, pp. 445-449
-
-
Rothermundt, M.1
Missler, U.2
Arolt, V.3
Peters, M.4
Leadbeater, J.5
Wiesmann, M.6
-
14
-
-
0038121680
-
Serum S100B increased during early treatment with antipsychotics and in deficit schizophrenia
-
Schroeter ML, Abdul-Khaliq H, Fruhauf S, Hohne R, Schick G, Diefenbacher A, et al. Serum S100B increased during early treatment with antipsychotics and in deficit schizophrenia. Schizophr Res 2003;62:231-6.
-
(2003)
Schizophr Res
, vol.62
, pp. 231-236
-
-
Schroeter, M.L.1
Abdul-Khaliq, H.2
Fruhauf, S.3
Hohne, R.4
Schick, G.5
Diefenbacher, A.6
-
16
-
-
1942420774
-
S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia
-
Rothermundt M, Ponath G, Glaser T, Hetzel G, Arolt V. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology 2004;29:1004-11.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 1004-1011
-
-
Rothermundt, M.1
Ponath, G.2
Glaser, T.3
Hetzel, G.4
Arolt, V.5
-
17
-
-
28244454204
-
Increased serum S100B in elderly, chronic patients: Negative correlation with deficit symptoms
-
Schmitt A, Bertsch T, Henning U, Tost H, Klimke A, Henn F, et al. Increased serum S100B in elderly, chronic patients: negative correlation with deficit symptoms. Schizophr Res 2005;80:305-13.
-
(2005)
Schizophr Res
, vol.80
, pp. 305-313
-
-
Schmitt, A.1
Bertsch, T.2
Henning, U.3
Tost, H.4
Klimke, A.5
Henn, F.6
-
18
-
-
33750683581
-
Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment
-
Ling SH, Tang YL, Jiang F, Wiste A, Guo SS, Weng YZ, et al. Plasma S-100B protein in Chinese patients with schizophrenia: comparison with healthy controls and effect of antipsychotics treatment. J Psychiatr Res 2007;41:36-42.
-
(2007)
J Psychiatr Res
, vol.41
, pp. 36-42
-
-
Ling, S.H.1
Tang, Y.L.2
Jiang, F.3
Wiste, A.4
Guo, S.S.5
Weng, Y.Z.6
-
19
-
-
0025338069
-
Selective increase in S-100 b protein by aging in rat central cortex
-
Kato K, Suzuki F, Morishita R, Asano T, Sato T. Selective increase in S-100 b protein by aging in rat central cortex. J Neurochem 1990;54:1269-74.
-
(1990)
J Neurochem
, vol.54
, pp. 1269-1274
-
-
Kato, K.1
Suzuki, F.2
Morishita, R.3
Asano, T.4
Sato, T.5
-
20
-
-
0037406288
-
Reference values for serum S-100B protein depend on the race of individuals
-
Ben Abdesselam O, Vally J, Adem C, Foglietti MJ, Beaudeux JL. Reference values for serum S-100B protein depend on the race of individuals. Clin Chem 2003;49:836-7.
-
(2003)
Clin Chem
, vol.49
, pp. 836-837
-
-
Ben Abdesselam, O.1
Vally, J.2
Adem, C.3
Foglietti, M.J.4
Beaudeux, J.L.5
|